ethinylestradiol + drospirenone


Laboratorios Leon Farma


Masa Lab
Concise Prescribing Info
Drospirenone 3 mg, ethinylestradiol 0.03 mg
Dosage/Direction for Use
1 tab daily for 21 days starting on the 1st day of menstruation, then 7 tab-free days.
Hypersensitivity. Adrenal insufficiency; hepatic function or renal impairment or in patients w/ conditions that predispose to hyperkalemia; known or suspected breast carcinoma, or endometrium carcinoma; known or suspected estrogen-dependent neoplasia; cardiac insufficiency; active or history of cerebrovascular disease/CAD; cholestatic jaundice of pregnancy or jaundice w/ prior pill use; cholestatic hepatic disease; history of benign or malignant hepatic tumors; thrombophlebitis, thrombosis or thromboembolic disorder; abnormal or undiagnosed uterine bleeding; HTN; DM. Pregnancy.
Special Precautions
Thrombosis or hepatic disease. History of thrombophlebitis, obesity, diabetes & HTN. Smoking especially in women >35 yr. Discontinue use if pregnancy occurs. Lactation.
Adverse Reactions
Nausea, abdominal pain; increased wt; headache; depressed mood, mood altered; breast tenderness, breast pain.
Drug Interactions
Concomitant use w/ primidone, phenytoin, barbiturates, carbamazepine, oxcarbazepine, topiramate, felbamate; rifampicin, rifabutin; ritonavir, nevirapine; penicillins, tetracyclines, griseofulvin & St. John's wort. Metabolism may be inhibited by ketoconazole, erythromycin & cyclosporine. Increase plasma & tissue conc of cyclosporine. Decrease plasma & tissue conc of lamotrigine. Angiotensin II antagonist (AIIA), diuretics, aldosterone antagonists; ACE inhibitors or indomethacin.
MIMS Class
Oral Contraceptives
ATC Classification
G03AA12 - drospirenone and ethinylestradiol ; Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
Justima tab
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in